Abstract:Background: Direct bronchial spread of tuberculosis was extensively described in pre-antibiotic human pathology literature but this description has been overlooked in the post-antibiotic era, in which most pathology data come from animal models that emphasise the granuloma. Modern techniques, such as [18F]2-fluoro-2-deoxy-D-glucose (FDG) PET-CT scans, might provide further insight. Our aim was to understand normal early tuberculosis resolution patterns on pulmonary PET-CT scans in treated patients with tuberculosis who were subsequently cured. Methods: In this observational analysis, we analysed data from PredictTB, an ongoing, prospective, randomised clinical trial that examined sequential baseline and week 4 FDG-PET-CT scans from participants successfully treated (sputum culture negative 18 months after enrolment) for drug-susceptible pulmonary tuberculosis in South Africa and China. Participants who were aged 18-75 years, GeneXpert MTB/RIF positive for tuberculosis and negative for rifampicin resistance, had not yet started tuberculosis treatment, had not been treated for active tuberculosis within the previous 3 years, and met basic safety laboratory criteria were included and participants with diabetes, HIV infection, or with extrapulmonary tuberculosis including pleural tuberculosis were excluded. Scans were assessed by two readers for the location of tuberculosis lesions (eg, cavities and consolidations), bronchial thickening patterns, and changes from baseline to week 4 of treatment. Findings: Among the first 124 participants (enrolled from June 22, 2017, to Sept 27, 2018) who were successfully treated, 161 primarily apical cavitary lesions were identified at baseline. Bronchial thickening and inflammation linking non-cavitary consolidative lesions to cavities were observed in 121 (98%) of 124 participants' baseline PET-CT scans. After 4 weeks of treatment, 21 (17%) of 124 participants had new or expanding lesions linked to cavities via bronchial inflammation that were not present at baseline, particularly participants with two or more cavities at baseline and participants from South Africa. Interpretation: In participants with pulmonary tuberculosis who were subsequently cured, the location of cavitary and non-cavitary lesions at baseline and new lesions at week 4 of treatment suggest a cavitary origin of disease and bronchial spread through the lungs. Bronchial spread from cavities might play a larger role in the spread of pulmonary tuberculosis than has been appreciated. Elucidating cavity lesion dynamics and Mycobacterium tuberculosis viability within cavities might better explain treatment outcomes and why some patients are cured and others relapse. Funding: Bill & Melinda Gates Foundation, European and Developing Countries Clinical Trials Partnership, China Ministry of Science and Technology, National Natural Science Foundation of China, and National Institutes of Health. Translations: For the Chinese, Afrikaans and Xhosa translations of the abstract see Supplementary Materials section.

Persistent bioaerosol release in a tuberculosis-endemic setting

Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols

Mycobacterium tuberculosis cough aerosol culture status associates with host characteristics and inflammatory profiles

Mycobacterium tuberculosis Transmission in High-Incidence Settings-New Paradigms and Insights

PneumoniaCheck, a novel aerosol collection device, permits capture of airborne Mycobacterium tuberculosis and characterisation of the cough aeromicrobiome in people with tuberculosis

Environmental air sampling for detection and quantification of Mycobacterium tuberculosis in clinical settings: Proof of concept

Assessing infectiousness and the impact of effective treatment to guide isolation recommendations for people with pulmonary tuberculosis

Estimating the contribution of subclinical tuberculosis disease to transmission: An individual patient data analysis from prevalence surveys

Tuberculosis: Current state of knowledge: An Epilogue

The transmission of tuberculosis in confined spaces: an analytical review of alternative epidemiological models

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis

Dynamic changes of respiratory microbiota associated with treatment outcome in drug-sensitive and drug-resistant pulmonary tuberculosis

Transcriptomic signatures of progression to TB disease among close contacts in Brazil

Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis

The Detection of Airborne Transmission of Tuberculosis from HIV-Infected Patients, Using an In Vivo Air Sampling Model

Role of Casual Contacts in the Recent Transmission of Tuberculosis in Settings with High Disease Burden.

Unexpectedly high strain diversity of Mycobacterium tuberculosis in a high-incidence community

Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township

Social-behavioral insights in understanding tuberculosis transmission pattern during the COVID-19 pandemic period in Kuala Lumpur, Malaysia: The MyTBNet study protocol

Molecular and microbiological methods for the identification of nonreplicating Mycobacterium tuberculosis